BAM
Blueshift Asset Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,457
| Closed | -$294K | – | 406 |
|
|
2024
Q3 | $294K | Buy |
+4,457
| New | +$294K | 0.07% | 283 |
|
|
2023
Q4 | – | Sell |
-3,289
| Closed | -$228K | – | 294 |
|
|
2023
Q3 | $228K | Buy |
+3,289
| New | +$228K | 0.13% | 231 |
|
|
2023
Q2 | – | Sell |
-2,567
| Closed | -$212K | – | 390 |
|
|
2023
Q1 | $212K | Buy |
+2,567
| New | +$212K | 0.09% | 294 |
|
|
2022
Q4 | – | Sell |
-5,086
| Closed | -$420K | – | 437 |
|
|
2022
Q3 | $420K | Buy |
+5,086
| New | +$420K | 0.09% | 320 |
|
|
2021
Q3 | – | Sell |
-2,642
| Closed | -$274K | – | 1081 |
|
|
2021
Q2 | $274K | Buy |
+2,642
| New | +$274K | 0.02% | 755 |
|
|
2021
Q1 | – | Sell |
-33,257
| Closed | -$3.03M | – | 914 |
|
|
2020
Q4 | $3.03M | Buy |
+33,257
| New | +$3.03M | 0.36% | 65 |
|
|
2019
Q2 | – | Sell |
-2,392
| Closed | -$458K | – | 775 |
|
|
2019
Q1 | $458K | Sell |
2,392
-6,438
| -73% | -$1.23M | 0.06% | 419 |
|
|
2018
Q4 | $1.35M | Buy |
+8,830
| New | +$1.35M | 0.25% | 94 |
|